20 May 2013
Keywords: cml, treatment, sprycel, launched, uk, usa-based, drug
Article | 11 December 2006
USA-based drug major Bristol-Myers Squibb has announced the UK launch of Sprycel (dasatinib), its drug for the treatment of chronic ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
11 December 2006
17 May 2013
© 2013 thepharmaletter.com